![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|7|7|681-688
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.7, Iss.7, 2007-11, pp. : 681-688
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Dutasteride chemoprevention worth it for prostate cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prostate cancer: dutasteride a good bet for chemoprevention . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prostate cancer chemoprevention: value rises with risk
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 606, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Wang Zhijun Fan Jeffery Liu Mandy Yeung Steven Chang Andy Chow Moses SS Pon Doreen Huang Ying
Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. :